Procter & Gamble’s earnings beat as higher pricing offsets drop in volume

Procter & Gamble on Wednesday reported quarterly earnings and revenue that topped analysts’ estimates as higher pricing helped offset lower demand for its products and currency headwinds.

The maker of Tide detergent, Charmin toilet paper and Pampers diapers also said it’s expecting foreign currency to hit its fiscal 2023 results more than previously expected. P&G said it’s now forecasting earnings per share on the low end of its prior range of flat to up 4%.

The stock rose 1.7% in premarket trading.

Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by Refinitiv:

• Earnings per share: $1.57 vs. $1.54 expected
• Revenue: $20.61 billion vs. $20.28 billion expected

For the three-month period ended Sept. 30, P&G reported a net income of $3.94 billion, or $1.57 per share, down from $4.11 billion, or $1.61 per share, a year earlier. The company’s gross margin fell 1.6% compared with the year-ago period, weighed down by higher freight and commodity costs.

Net sales rose 1% to $20.61 billion, topping expectations of $20.28 billion. Unfavorable foreign exchange rates dragged revenue down by 6%.

When stripping out the impact of acquisitions, divestitures and foreign currency, the company said organic revenue climbed 7% in the quarter. Higher prices fueled organic sales growth and offset a 3% volume decline.

The company has been raising prices on products to mitigate rising costs, but the strategy has hurt consumer demand for its products, leading to shrinking volume for the last two fiscal quarters.

P&G’s grooming business, which includes Gillette and Venus razors, was the company’s only unit to report volume growth for the quarter. The segment’s volume rose 1%, although the company noted a slowdown in grooming appliances.

There were a few other bright spots for P&G’s volume. Skin and personal care, which is part of the company’s beauty segment, saw higher demand, fueled by new and upgraded products. A strong cold and flu season drove volume growth of its personal health care segment, which includes brands like Vicks and Zzzquil.

For fiscal 2023, P&G’s net sales are expected to decline 1% to 3%, lower than its previous outlook of flat to up 2%, due to foreign currency.

This story is developing. Please check back for updates.